Argenx Se (ARGX) Accumulated Expenses (2015 - 2023)
Argenx Se (ARGX) posted Accumulated Expenses of $95.1 million for Q4 2023, up 12.77% on a QoQ basis from $84.3 million in Q4 2022, and up 12.77% year-over-year from $84.3 million in Q4 2022.
Argenx Se (ARGX) Accumulated Expenses (2015 - 2023) Analysis & Trends
Argenx Se's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $95.1 million for Q4 2023.
- Quarterly Accumulated Expenses rose 12.77% year-over-year to $95.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $95.1 million (up 12.77% YoY) and the FY2023 annual result came in at $95.1 million, up 12.77% from the prior year.
- Accumulated Expenses was $95.1 million for Q4 2023 at Argenx Se, up from $84.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $95.1 million in Q4 2023 and bottomed at $30.2 million in Q4 2019.
- A 5-year average of $72.4 million and a median of $83.7 million in 2021 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2020 — Accumulated Expenses surged 128.13% — and 2022, when it gained 0.72%.
- Argenx Se's Accumulated Expenses stood at $30.2 million in 2019, then jumped by 128.13% to $68.9 million in 2020, then increased by 21.59% to $83.7 million in 2021, then grew by 0.72% to $84.3 million in 2022, then increased by 12.77% to $95.1 million in 2023.
- Business Quant data shows ARGX's Accumulated Expenses at $95.1 million in Q4 2023, $84.3 million in Q4 2022, and $83.7 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 95.10 Mn |
| Dec 31, 2022 | 84.34 Mn |
| Dec 31, 2021 | 83.74 Mn |
| Dec 31, 2020 | 68.87 Mn |
| Dec 31, 2019 | 30.19 Mn |
| Dec 31, 2017 | 8.06 Mn |
| Dec 31, 2016 | 2.55 Mn |
| Dec 31, 2015 | 1.55 Mn |